Dr Peter Houweling is a Team leader and senior research officer in the Muscle Research group at the Murdoch Children’s Research Institute (MCRI). He completed his PhD at the University of Sydney and post-doctoral appointments at the Children’s Hospital Westmead, before moving the MCRI in 2013.
He has almost 15 years of experience in the laboratory where he is working to understand the impact of genetic variants on skeletal muscle performance in health and disease.
His Team now focuses on using stem cells to model and test new treatments for patients with genetic muscle diseases, including Duchenne muscular dystrophy (DMD), Facioscapulohumeral muscular dystrophy (FSHD) and other congenital muscular dystrophies.
Dr Peter Houweling is a Team leader and senior research officer in the Muscle Research group at the Murdoch Children’s Research Institute (MCRI). He completed his PhD at the University of Sydney and post-doctoral appointments at the Children’s...
Dr Peter Houweling is a Team leader and senior research officer in the Muscle Research group at the Murdoch Children’s Research Institute (MCRI). He completed his PhD at the University of Sydney and post-doctoral appointments at the Children’s Hospital Westmead, before moving the MCRI in 2013.
He has almost 15 years of experience in the laboratory where he is working to understand the impact of genetic variants on skeletal muscle performance in health and disease.
His Team now focuses on using stem cells to model and test new treatments for patients with genetic muscle diseases, including Duchenne muscular dystrophy (DMD), Facioscapulohumeral muscular dystrophy (FSHD) and other congenital muscular dystrophies.
Top Publications
Houweling, PJ.
The antioxidants neopterin/7,8‐dihydroneopterin: Novel biomarker and muscle protectant in Duchenne muscular dystrophy.
Experimental Physiology
103(7)
:
939 -940
2018
view publication
Kiriaev, L, Kueh, S, Morley, JW, North, KN, Houweling, PJ, Head, SI.
Branched fibers from old fast-twitch dystrophic muscles are the sites of terminal damage in muscular dystrophy.
American Journal of Physiology - Cell Physiology
314(6)
:
c662 -c674
2018
view publication
Garton, FC, Houweling, PJ, Vukcevic, D, Meehan, LR, Lee, FXZ, Lek, M, Roeszler, KN, Hogarth, MW, Tiong, CF, Zannino, D, et al.
The Effect of ACTN3 Gene Doping on Skeletal Muscle Performance.
American Journal of Human Genetics
102(5)
:
845 -857
2018
view publication
Houweling, PJ, Berman, YD, Turner, N, Quinlan, KGR, Seto, JT, Yang, N, Lek, M, Macarthur, DG, Cooney, G, North, KN.
Exploring the relationship between α-actinin-3 deficiency and obesity in mice and humans.
International Journal of Obesity
41(7)
:
1154 -1157
2017
view publication
Levinger, I, Yan, X, Bishop, D, Houweling, PJ, Papadimitriou, I, Munson, F, Byrnes, E, Vicari, D, Brennan-Speranza, TC, Eynon, N.
The influence of α-actinin-3 deficiency on bone remodelling markers in young men.
Bone
98:
26 -30
2017
view publication